Suchergebnisse - "Rahman, Omar"

PubPharm (11)

1

Clinical correlates and prognostic value of different metastatic sites in metastatic renal cell carcinoma

enthalten in: Future oncology | 2017

von Abdel-Rahman, O.

2

Impact of the staging method on the prognostic utility of the 8th AJCC staging system for non-small-cell lung cancer

enthalten in: Future oncology | 2017

von Abdel-Rahman, O.

3

Dissecting the heterogeneity of stage III non-small-cell lung cancer through incorporation of grade and histology

enthalten in: Future oncology | 2017

von Abdel-Rahman, O.

4

Risk of selected gastrointestinal and hepatic toxicities in cancer patients treated with nintedanib: a meta-analysis

enthalten in: Future oncology | 2016

von Abdel-Rahman, O. | Bahie Eldin, N. | ElHalawani, H.

5

Risk of selected dermatological toxicities in cancer patients treated withMEKinhibitors: a comparative systematic review and meta-analysis

enthalten in: Future oncology | 2015

von Abdel-Rahman, O. | ElHalawani, H. | Ahmed, H.

6

Risk of hematological toxicities in patients with solid tumors treated with ramucirumab: a meta-analysis

enthalten in: Future oncology | 11, 21, Seite 2949-2961

von Abdel-Rahman, O. | ElHalawani, H.

7

Targeting BRAF aberrations in advanced colorectal carcinoma: from bench to bedside

enthalten in: Future oncology | 12, 1, Seite 25-30

von Abdel-Rahman, O.

8

Rolapitant: a pooled analysis of its efficacy and safety in the prophylaxis of chemotherapy-induced nausea and vomiting

enthalten in: Future oncology | 12, 6, Seite 871-879

von Abdel-Rahman, O. | Fouad, M.

9

S-1-based regimens for locally advanced/metastatic non-small-cell lung cancer: a meta-analysis

enthalten in: Future oncology | 12, 5, Seite 701-713

von Abdel-Rahman, O. | ElHalawani, H.

10

Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis

enthalten in: Future oncology | 12, 3, Seite 413-425

von Abdel-Rahman, O. | ElHalawani, H. | Fouad, M.